Patent Expiry

Patent/Exclusivity Expiry: ZYPITAMAG

Other upcoming events for MCUJF

Phase 3 ReadoutPhase 3 Topline: Study of Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Patent/Exclusivity Expiry: ZYPITAMAG — MCUJF Patent Expiry | BioSniper